We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Assay Released for Free Protein S Antigen Testing

By LabMedica International staff writers
Posted on 11 Sep 2012
An assay for easy, specific, and stable free protein S antigen (PS Ag) testing employs polystyrene particles coated with monoclonal antibodies for specific determination of free protein S (PS).

Siemens Healthcare Diagnostics (Tarrytown, NY, USA) unveiled its INNOVANCE Free PS Ag assay, which will help labs complete their thrombophilia testing portfolio on the company's automated hemostasis systems. The test is not available for sale in the USA.

A plasma protein manufactured in the liver, Protein S is an anticoagulant that functions as a cofactor for protein C-mediated inhibition of activated factors V and VIII. Those with protein S deficiency, whether congenital or acquired, are at greater risk for venous thrombosis. Therefore, testing for protein S plays an important role in thrombophilia screening.

The new test complements Siemens' existing protein S activity assay (Protein S Ac) and enables the company to provide a complete protein S testing menu to labs. When combined with existing Siemens thrombophilia assays—all optimized for use with the Siemens BCS and Sysmex analyzers—the INNOVANCE Free PS Ag assay completes clinical labs’ thrombophilia testing portfolio.

The INNOVANCE Free PS Ag assay demonstrates linearity and precision over the calibrated measuring range, as well as specificity for free protein S antigens with no major interferences, including those commonly incurred from rheumatoid factors and heterophilic antibodies.

“Specificity, stability, and ease of use are key drivers behind a laboratory’s confidence in an assay, as these factors directly contribute to results accuracy and decreased error potential,” said Michael Noeh, vice president, Global Marketing Hematology, Hemostasis, and Specialty Business Unit, Siemens Healthcare Diagnostics. “The Siemens INNOVANCE Free PS Ag assay not only successfully delivers these key factors; it also enables laboratories to complete their thrombophilia testing panel.”

Related Links:

Siemens Healthcare Diagnostics




New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Alpha-Fetoprotein Reagent
AFP Reagent Kit
New
Hemoglobin/Haptoglobin Assay
IDK Hemoglobin/Haptoglobin Complex ELISA

Latest Immunology News

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions